bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2015.
bioMérieux - First Quarter 2015 Business Review
Office of The French Consul General to visit bioMérieux’s St. Louis headquarters in recognition of leadership in diagnostics
The Consul General of France in Chicago, Vincent Floréani, and Honorary Consul General of France in St. Louis, James F. Mauzé, Jr., are scheduled to visit bioMérieux’s St. Louis facility April 14, 2015.
bioMérieux Educates and Engages Future Microbiologists at the Triangle SciTech Expo
bioMérieux is working to draw new talent into the field by creating a fun and educational exhibit at the Triangle SciTech Expo for the second year in a row.
USDA adds bioMérieux TEMPO® System to Microbiology Laboratory Guidebook, the Standard-Setting Guideline for Food-Safety Testing in the U.S.
TEMPO®’s automated food quality testing will help improve food safety nationwide
bioMérieux - 2014 Financial Results
Solid growth in sales: Up 8.7%, including BioFire and at constant exchange rates Up 3.8%, at constant exchange rates and scope of consolidation
bioMérieux to present the latest pharmaceutical monitoring technology, Labguard® 3D, at local Technology conference
Durham, NC – March 10, 2014 - bioMérieux Industry, a bioMérieux unit dedicated to industrial application diagnostics, will be present as a corporate partner and exhibitor at the ISPE Carolina-South Atlantic Chapter’s 22nd Annual Life Sciences Technology Conference.
BioFire Receives FDA Clearance for the FilmArray® 2.0 System
New system delivers higher throughput, single database management and minimized footprint
Visiting bioMérieux’s North American Headquarters in Durham, French Consul General Recognizes bioMérieux U.S. Leadership in Rapid Identification of Infectious Diseases
French Consul General Denis Barbet, accompanied by the new scientific, cultural, and press attachés, Anne Corval, Alexandre Durand, and Heather Clavé, spent the morning Wednesday, February 4, at the North American headquarters of bioMérieux in Durham, North Carolina.
BioFire Defense, a bioMérieux Company, Receives Prestigious Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola Test
BioFire Defense, LLC is proud to announce that it is the recipient of the Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola test. The New Product Innovation Award is given to companies that display strong overall performance in the development and market of an innovative new product, including adherence to U.S. Food and Drug Administration (FDA) criteria for Emergency Use Authorization (EUA)* and design of a product that addresses unmet needs.